Department of Physiology, The University of Arizona, and The Benjamin W. Zweifach Microcirculation Laboratories, Department of Veteran Affairs Medical Center, Tucson, Arizona 85723
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Thrombin-induced endothelial monolayer hyperpermeability is thought to
result from increased F-actin stress fiber-related contractile tension,
a process regulated by the small GTP-binding protein Rho. We tested
whether this process was dependent on the Rho-associated protein
kinase, ROCK, using a specific ROCK inhibitor, Y-27632. The effects of
Y-27632 on thrombin-induced myosin light chain phosphorylation (MLCP)
and tyrosine phosphorylation of p125 focal adhesion kinase
(p125FAK) and paxillin were measured by Western blotting.
F-actin organization and content were analyzed by digital imaging, and
endothelial monolayer permeability was measured in bovine pulmonary
artery endothelial cell (EC) monolayers using a size-selective
permeability assay. Y-27632 enhanced EC monolayer barrier function due
to a decline in small-pore number that was associated with increased EC
surface area, reduced F-actin content, and reorganization of F-actin to
-catenin-containing cell-cell adherens junctions. Although Y-27632
prevented thrombin-induced MLCP, stress fiber formation, and the
increased phosphotyrosine content of paxillin and p125FAK,
it attenuated but did not prevent the thrombin-induced formation of
large paracellular holes. These data indicate that thrombin-induced stress fiber formation is ROCK dependent. In contrast, thrombin-induced paracellular hole formation occurs in a ROCK-independent manner, whereas thrombin-induced monolayer hyperpermeability appears to be
partially ROCK dependent.
nonmuscle myosin; myosin light chain phosphorylation; paxillin; Y-27632; immunofluorescent digital imaging; Rho-associated coiled-coil forming kinase
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
HYPERPERMEABILITY of the blood vessel wall permits leakage of excess fluids and protein into the interstitial space. This acute inflammatory event is frequently allied with tissue ischemia and acute organ dysfunction. Thrombin formed at sites of activated endothelial cells (EC) initiates this microvessel barrier dysfunction due to the formation of large paracellular holes between adjacent EC. This process features changes in EC shape due to myosin light chain phosphorylation (MLCP) that initiates the development of F-actin-dependent cytoskeletal contractile tension (1, 10, 12, 17).
The signaling mechanism of this contractile process involves the
proteolytic cleavage and activation of the thrombin receptor. This
receptor is coupled to heterotrimeric G proteins of the Gq family that stimulate phospholipase C to release
D-myo-inositol 1,4,5-trisphosphate, mobilizing
Ca2+ from intracellular stores (10,
17). The subsequent rise in intracellular Ca2+
concentration activates Ca2+-calmodulin-dependent MLC
kinase, which phosphorylates serine-19 and threonine-18 of MLC
(11). MLCP initiates myosin Mg2+-ATPase
activity, causing the binding of myosin to F-actin and subsequent
actomyosin stress fiber formation (20). The
phosphorylation of MLC converts the soluble folded 10S form of
nonmuscle myosin II to the insoluble unfolded 6S form. This process is
characterized by reorganization of myosin from a diffuse intracellular
cloud to punctate spots and ribbons associated with large bundles of F-actin (28). The phosphorylation of MLC is also adjusted
by the activity of the MLC-associated phosphatase (PP1M). PP1M is composed of three components: a 130-kDa regulatory subunit, a 37-kDa
catalytic subunit, and a 20-kDa subunit. Recently, it has been shown
that the Rho-associated serine/threonine kinase
/p160, or
Rho-associated coiled-coil forming kinase (ROCK) inactivates PP1M
through the phosphorylation of the 130-kDa PP1M subunit
(19). Thus RhoA-activated ROCK inhibits PP1M activity and
elevates MLC phosphorylation, myosin ribbon and stress fiber formation,
and endothelial contractile tension (3, 4,
15).
The RhoA, B, and C small GTP-binding proteins have been implicated in the modulation of the F-actin cytoskeleton and cell shape (21). Rho proteins are active in their GTP-bound form and inactive when bound to GDP. Guanine nucleotide exchange factors and GTPase activating proteins regulate this control switch. Constitutively active V14RhoA initiates the formation of actomyosin stress fibers and focal adhesions, causing tyrosine phosphorylation of the focal adhesion proteins paxillin and p125 focal adhesion kinase (p125FAK) and a contracted morphology in fibroblasts (3, 6, 21). Rho substrates that include phosphatidylinositol 3-kinase (PI 3-kinase), PI 5-kinase, mDia (a mammalian diaphanous homologue), and ROCK modulate the F-actin cytoskeleton (5, 18, 29). Whereas mDia directly stimulates the formation of F-actin by activation of the actin-binding protein profilin, activated ROCK indirectly initiates polymerization of the actin cytoskeleton by two mechanisms: 1) increasing MLCP, and 2) inhibiting the activity of cofilin, an actin-severing protein. The latter is modulated by ROCK-dependent activation of LIM kinase (3, 9, 18). Together, these findings show that activated ROCK modulates the formation of F-actin stress fibers both by promotion of actin polymerization and prevention of actin depolymerization. Recent findings have shown that a specific inhibitor of ROCK, Y-27632, prevents smooth muscle contraction and the formation of F-actin stress fibers, indicating that Rho proteins modulate these processes (18, 27). These data also suggest that Y-27632 may be useful to assess the role of endothelial contraction in thrombin-induced EC monolayer hyperpermeability.
Thrombin-induced endothelial hyperpermeability may also be mediated by
changes in cell-cell adhesion (7). Endothelial cell-cell adhesion is determined primarily by the function of vascular
endothelial cadherin (cadherin 5), a Ca2+-dependent
cell-cell adhesion molecule that forms adherens junctions. Cadherin 5 function is regulated from the cytoplasmic side through association
with the accessory proteins -catenin, plakoglobin (
-catenin), and
p120 that are linked, in turn, to
-catenin (homologous to vinculin)
and the F-actin cytoskeleton. Whether the Rho family of GTPases
modulates this process is not known.
In the present study, we tested the hypothesis that thrombin-induced stress fiber formation and thrombin-induced paracellular hole formation are ROCK-dependent processes. Y-27632 inhibited thrombin-induced MLCP and stress fiber formation, indicating that these processes are ROCK dependent. Because Y-27632 attenuated but did not avert thrombin-induced paracellular hole formation, the mechanisms of thrombin-induced endothelial hyperpermeability appear to be due to a combination of ROCK-dependent increases in EC contractile tension and ROCK-independent events.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cell culture. Our personal stock of low-passage (passages 5-11) EC, isolated from bovine pulmonary arteries as previously described (24), was grown in DMEM containing 10% FCS (Hyclone, Ogden, UT) and used between 3 and 4 days postconfluence.
Immunoprecipitation and immunoblotting.
EC grown in gelatin-coated 60-mm dishes were treated with or without
1-50 µM Y-27632 (Yoshitomi Pharmaceutical Industries, Saitama,
Japan) in the presence or absence of human -thrombin (10 U/ml;
Sigma, St. Louis, MO). After the appropriate treatments, EC were lysed
in extraction buffer and immunoprecipitated for phosphotyrosine
(PY)-containing proteins using 2 µg of monoclonal antibodies, PY-99
(Santa Cruz Biotechnology, Santa Cruz, CA), or paxillin using
anti-paxillin IgG (Transduction Laboratories, Lexington, KY) as
previously described (4). After capture with protein G
agarose, the pellets were washed, boiled with 2× SDS sample buffer
under reducing conditions for 5 min, and separated by SDS-PAGE in 7.5%
vertical slab gels using a Laemmli buffer system. Proteins were
transferred to nitrocellulose (Schleicher and Schuell, Keene, NH) and
the membranes immunoblotted with antibodies to anti-phosphotyrosine
(4G10; Upstate Biotechnology, Lake Placid, NY) or monoclonal IgG to
p125FAK or paxillin, followed by Enhanced Chemiluminescence
(ECL) Plus detection (Amersham, Arlington Heights, IL). X-ray films
developed at various intervals were used to detect each protein within
the linear range of the film.
Endothelial monolayer barrier function. The techniques listed herein have been described in detail elsewhere (22, 24-26). In brief, the size-dependent passage of fluorescein isothiocyanate-labeled hydroxyethyl starch (FITC-HES) macromolecules across bovine pulmonary artery EC monolayers was used to measure the presence or absence of a small-pore barrier. FITC-HES samples from both sides of the monolayer/filter support barrier were analyzed by high-pressure size-exclusion liquid chromatography (HPSEC) and quantified with a fluorescence spectrophotometer-computer detection system (26).
EC monolayers were prepared by seeding 75 × 103 cells onto gelatin/fibronectin-coated Transwell inserts (2,000 Å pore radius filter supports, 0.33 cm2 surface area; Costar, Cambridge, MA) in a 24-well plate. At 4-5 days postconfluence, each monolayer was incubated with Y-27632 for 1 h as indicated in the text. Barrier function studies were performed by washing each Transwell with 37°C serum-free HEPES-buffered (pH = 7.4) MEM. The experiment was initiated by the addition of 100 µl of FITC-HES (3 mg/ml) to the top chamber (Transwell insert) and 650 µl of serum-free HEPES-MEM to the bottom chamber (24-well plate) followed by Y-27632 and/or 10 U/ml of thrombin. Samples (30 µl) from the bottom and top chambers were removed after 1.5 h. Computation of permeability/free diffusion coefficients was performed exactly as previously described (25). Monolayer experiments that did not achieve restricted diffusion in controls were excluded from this study.Digital imaging immunofluorescence microscopic workstation.
The digital imaging microscopic workstation used in these studies has
been previously described (4). In brief, an Olympus IMT-2
microscope with an Olympus ×60 magnification, 1.4 numerical aperture
oil-immersion objective, a 150-W xenon lamp, a MetalTek filter wheel,
and a Chroma Technology 84 series quad filter set polychromatic
beamsplitter/emitter (Chroma Technology, Brattleboro, VT) were used to
simultaneously collect Alexa 488, tetramethylrhodamine (TRITC), or Cy5
staining pattern for each sample. Epifluorescent digital images
were collected with online background subtraction and shading
correction at 12-bit depth using a Photometrics (Tucson, AZ) PXL
charge-coupled device camera containing a Kodak 1400 chip that was
thermostatically cooled to 25°C to reduce dark current noise and
controlled with MetaMorph software (Universal Imaging, Version
4.0). MetaMorph was used to identify regions of colocalization by color coding the separate immunofluorescent images of each cell.
Labeling of cytoskeletal structures.
EC grown to 4 days postconfluence in Transwell membranes or eight-well
slides were treated and stained as described in the text. Primary
monoclonal antibodies to -catenin (no. 13-8400, 1:100 dilution;
Zymed Laboratories) or rabbit IgG to
-catenin (no. 71-1200,
1:50 dilution) were used to detect the adherens junctions, mouse
anti-paxillin IgG (1:200 dilution; Chemicon, Temecula, CA) was used to
detect focal adhesions, and affinity-purified rabbit antibodies to
nonmuscle myosin II (BT-561, 1:25 dilution; Biomedical Technologies)
were used to label myosin II. After washing, secondary goat TRITC or
Cy5-labeled anti-rabbit IgG (1:25 dilution) and goat-Cy5 anti-mouse IgG
(1:25 dilution; Jackson Immunoresearch Labs, Westgrove, PA) were used
to label each primary IgG. Alexa 488 or TRITC-phalloidin (Molecular
Probes, Eugene, OR) was used to label F-actin. The Transwell membranes
were removed and placed on a glass slide, and the slide was covered
with Vectashield mounting medium (Vector Laboratories, Burlingame, CA).
A no. 1 coverslip was applied, and the edges were sealed with nail polish.
MLCP. The phosphorylation of MLC was measured by urea/glycerol PAGE separation of the mono- and diphosphorylated forms as previously described (9, 20). EC grown in 60-mm dishes were stimulated with thrombin in the presence or absence of Y-27632 as indicated, and the reaction was stopped by the addition of 1 ml of ice-cold 10% perchloric acid. Cells were scraped and centrifuged for 10 min at 20,000 g at 4°C. The pellets were washed with 1 ml of ice-cold water followed by 1 ml of ice-cold ethanol, and the pellet was redissolved in sample buffer (6.7 M urea, 10 mM Tris, 22 mM glycine, and 270 mM sucrose, pH 9.0). Equal amounts of protein were added to each lane of a 40% glycerol/10% acrylamide gel and run at 400 V for ~1 h. The protein samples were transferred to nitrocellulose in 0.25 mM phosphate buffer (pH 7.6) for ~1 h. The unphosphorylated (P0), monophosphorylated (P1), and diphosphorylated (P2) forms of MLC were detected by Western blotting using a polyclonal MLC antibody (1:1,000; James Stull, Dallas, Texas) followed by detection using ECL Plus (Amersham) and a Storm phosphoimager (Molecular Dynamics). The stoichiometry of MLCP (moles of phosphate per moles of MLC) was determined using Imagequant software and calculated using the formula P1 + 2 × P2/P0 + P1 + P2 as previously described (9).
Statistical analysis of EC surface area and F-actin content.
Digital images of the F-actin and -catenin staining patterns were
collected (10 images/treatment) at random from Transwell membranes
exposed to thrombin with or without Y-27632 pretreatment as indicated
in the text. EC surface area and F-actin content were determined as
previously described (4). The Student's test (paired) was
used for the statistical analysis of the results. These values are
expressed as means ± SE.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Y-27632 enhances monolayer barrier function and attenuates
thrombin-induced endothelial monolayer hyperpermeability.
Rho proteins have been reported to adjust thrombin-induced MLCP and
F-actin stress fiber formation in endothelial cells, leading to the
loss of EC barrier function (2, 9). We
quantitatively measured the size and number of paracellular holes
formed across thrombin-stimulated EC monolayers in the presence or
absence of the specific ROCK inhibitor Y-27632 by analyzing their
size-selective solute permeability characteristics using an HPSEC
technique (26). Restricted diffusion, created by
predominantly small "pores" (<250 Å pore radius), is
characterized by a decline in the size-selective permeability/free
diffusion coefficient (P/Do) with
increasing solute molecular radius (ae)
(24). In contrast, the formation of large holes (>2,000
Å pore radius) is displayed by an increase in
P/Do for solutes with large molecular
radii (25). Control EC monolayers showed
significant restricted diffusion, a property that was
enhanced by pretreatment with 5, 10, and 50 µM Y-27632 (Fig.
1A). In contrast,
thrombin-stimulated monolayers displayed large hole barrier
hyperpermeability as illustrated by a shift in the
P/Do vs. ae
curve up and to the right. Although Y-27632-thrombin-treated monolayers
displayed P/Do values that were
substantially lower than those for monolayers exposed to thrombin
alone, these values were significantly greater than those for Y-27632
alone as well as above the control
P/Do for
ae > 60 Å (Fig. 1B). Similar
effects were seen when 5 or 50 µM Y-27632 was used in the presence or absence of thrombin (data not shown).
|
Y-27632 reorganizes the F-actin cytoskeleton to
-catenin-containing adherens junctions but does not avert
thrombin-induced paracellular hole formation.
Adherens junctions, characterized by homophilic binding of
Ca2+-dependent adhesion (cadherins) molecules, are linked
to the F-actin cytoskeleton by the accessory proteins
-,
-, and
-catenin (7). To test whether Y-27632 stimulated the
reorganization of F-actin and prevented thrombin-induced large hole
formation, Transwell membranes from the barrier function assays listed
above were fixed and double stained for F-actin and the adherens
junctional protein
-catenin. Control EC displayed a few F-actin
stress fibers (Fig. 2, A and C,
arrows) and some F-actin at the
-catenin-containing cell-cell junctions (Fig. 2, B and
C, arrowheads). Thrombin stimulated the formation of
large F-actin stress fibers (Fig. 2, D and F, arrows) and large paracellular holes that did not show
-catenin staining (Fig. 2, D-F, asterisks). A fingerlike
-catenin
staining pattern appeared linked to large F-actin filament bundles
(Fig. 2, E and F, arrowheads).
Y-27632-treated (10 µM) EC displayed no F-actin stress fibers because
most F-actin was colocalized with
-catenin at cell-cell junctions
(Fig. 3, A-C,
arrowheads), characteristics that
remained in 10 µM Y-27632-thrombin-treated monolayers (Fig. 3,
D-F). Thrombin-induced paracellular hole formation remained
present in the 10 µM Y-27632-thrombin-treated monolayers (Fig. 3,
D-F, asterisks). Similar effects were observed in 5 and 50 µM Y-27632-thrombin-treated monolayers (data not shown).
|
|
Y-27632 decreases F-actin content, increases EC surface area, and
prevents thrombin-induced increases in F-actin content.
The role of the F-actin cytoskeleton in the modulation of endothelial
barrier function remains controversial. Bacterial toxins that decrease
F-actin content have been shown to enhance or degrade endothelial
monolayer barriers (2, 13). In the present
report, measurements of F-actin content (F-actin intensity per unit
cell surface area, FI/µm2) showed that Y-27632 initiated
up to a 30% decline in F-actin content that was most marked at 5 µM
(Fig. 4A). Higher (10-50 µM) amounts of Y-27632 displayed less difference in
FI/µm2 compared with the control group. This effect was
associated with the increased appearance of amorphous F-actin pools in
these EC (data not shown). Although the F-actin content of the thrombin group was significantly above the control group, the Y-27632-thrombin treatments showed a 20-30% decline in F-actin content values
compared with the effects of thrombin alone.
|
Y-27632 prevents thrombin-induced MLCP.
Thrombin is known to stimulate the rapid phosphorylation of MLC,
achieving a maximum within 2 min and initiating the EC contractile forces associated with EC monolayer hyperpermeability (10,
11). We tested the concentration-dependent effects of
Y-27632 to prevent the thrombin-induced phosphorylation of MLC (Fig.
5). EC monolayers were pretreated with
Y-27632 (1-50 µM, 1 h), followed by stimulation with 10 U/ml of thrombin for 2 min. The P0, P1, and
P2 forms of MLC were separated (Fig. 5A),
quantified by densitometry, and expressed as moles of phosphate per
moles of MLC (Fig. 5B) as described in MATERIALS AND
METHODS. Thrombin stimulated the rapid incorporation of phosphate
into MLC that was 1.8-fold above control after 2 min. Pretreatment with
5-10 µM Y-27632 prevented this thrombin effect, whereas 50 µM
reduced MLCP below control levels.
|
Y-27632 reorganizes nonmuscle myosin II and prevents
thrombin-induced myosin ribbon formation.
Thrombin-induced formation of MLCP initiates the reorganization of
myosin from spots into ribbons along large actin filament bundles
(11, 28). We tested whether Y-27632 prevented
thrombin-induced myosin ribbon formation by immunostaining Transwell
membranes with antibodies to nonmuscle myosin from the permeability
experiments listed above. Control EC exhibited a few myosin spots (Fig.
6A, arrowheads,
inset). Thrombin
initiated the formation of multiple myosin ribbons across EC and at the
cell borders (Fig. 6B, arrowheads, inset). These effects were not seen in Y-27632-pretreated
EC, which exhibited a diffuse myosin immunostaining pattern in the presence and absence of thrombin (Fig. 6, C and
D).
|
Y-27632 inhibits tyrosine phosphorylation of the focal adhesion
proteins paxillin and p125FAK.
Thrombin stimulates the formation of focal adhesions at the ends of
F-actin stress fibers and initiates the tyrosine phosphorylation of the
focal adhesion proteins paxillin and p125FAK,
events that are sensitive to the Rho protein inhibitor C3 exoenzyme and
the MLC kinase inhibitor KT-5926 (4, 23). We
tested whether Y-27632 prevented tyrosine phosphorylation of specific
focal adhesion proteins in thrombin-stimulated EC by
immunoprecipitation with anti-paxillin and anti-phosphotyrosine (PY-99)
antibodies followed by Western blot analyses with anti-phosphotyrosine
(4G10), anti-p125FAK, and anti-paxillin IgG (Fig. 7,
A-D). Although Y-27632 did
not affect the quantity of immunoprecipitated paxillin (Fig.
7B), this inhibitor stimulated a decline in the PY content
of two protein bands, paxillin and p125FAK, with or without
thrombin treatment (Fig. 7, A, C, and
D).
Densitometry of the thrombin-stimulated PY-containing
proteins revealed an increase in the PY content of paxillin and
p125FAK (Fig. 7, C and D). Because
Y-27632 prevented these changes in the presence or absence of thrombin,
these tyrosine phosphorylation events appear to be ROCK dependent.
|
|
Y-27632 inhibits thrombin-induced formation of paxillin-containing
focal adhesions.
Finally, we tested whether Y-27632 prevented thrombin-induced formation
of focal adhesions. EC monolayers, pretreated with Y-27632 (10 µM, 1 h) followed by the presence or absence of thrombin (10 U/ml, 0.5 h), were triple stained for F-actin, paxillin, and -catenin (Fig. 8). Figure 8, A-D, shows a control EC
that displays dense peripheral bands of F-actin (A,
arrows) with few focal adhesions (B,
arrowheads) and
-catenin-containing adherens junctions
(C, arrows) that are merged into a tricolor image
(D). In contrast, thrombin stimulated the formation of
F-actin stress fibers (Fig. 8, E and H,
arrows) linked to paxillin-containing focal adhesions (Fig. 8, F and H, arrowheads and
insets). Y-27632 in the presence or absence of thrombin
reorganized F-actin (arrows) and paxillin (arrowheads) to
-catenin-containing cell-cell
adhesions (Fig. 8, I-P, arrows).
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
With the use of pulmonary artery EC monolayers as an in vitro
analog of blood vessel barrier function and Y-27632 as a specific ROCK
inhibitor, we tested the hypothesis that thrombin-induced EC barrier
hyperpermeability was due to ROCK-dependent formation of actomyosin
stress fibers. Y-27632-treated EC displayed the disassembly of
actomyosin stress fibers with reorganization of F-actin to - or
-catenin-containing adherens junctions. These effects, in
combination with an increase in EC surface area and decline in F-actin
content, characterize the Y-27632-dependent enhancement of EC monolayer
barrier function. Although this inhibitor prevented the
thrombin-induced phosphorylation of MLC, myosin ribbon formation, and
increased F-actin content, Y-27632 treatment attenuated but did not
avert thrombin-induced monolayer barrier hyperpermeability or the loss
of
-catenin staining at sites of paracellular hole formation. These
data show that ROCK regulation of the endothelial F-actin cytoskeleton
plays an important role in the modulation of endothelial monolayer
barrier function. Inhibition of ROCK improves monolayer barrier
function by a mechanism that elevates EC surface area in association
with a decline in the number of small paracellular pores. In addition,
ROCK mediates thrombin-induced development of actomyosin stress fibers
linked to focal adhesions. However, Y-27632 inhibition of ROCK does not completely prevent paracellular hole formation, implying that thrombin-induced monolayer hyperpermeability is partially mediated by
ROCK-independent noncytoskeletal forces.
Activated Rho proteins regulate the formation of the F-actin
cytoskeleton by activation of PI 3-kinase, PI 5-kinase, mDia, and ROCK
(5, 18, 29). Whereas the PI
kinases and mDia initiate actin polymerization, ROCK inhibits the
depolymerization of F-actin. In addition, ROCK indirectly stimulates
the formation of F-actin stress fibers by inhibiting myosin phosphatase
(18). Y-27632 appears to inhibit these processes in a
ROCK-dependent manner because Y-27632 shows a 2,000 times greater
affinity for ROCK than for protein kinase C (PKC) using purified enzyme
substrates (27). These data, in combination with the
observation that 10 µM Y-27632 maximally inhibits ROCK-dependent
smooth muscle cell contraction and higher amounts nonselectively
inhibit both PKC and cAMP-dependent protein kinase, indicate that 10 µM Y-27632 selectively suppresses ROCK-dependent formation of F-actin
as shown in LIM kinase 1-expressing HeLa cells (18,
27). Consistent with these data, we report that Y-27632
reduces F-actin stress fibers, F-actin content, and MLCP and initiates
a diffuse myosin staining pattern at concentrations (5-10 µM)
that are selective for ROCK in other cell types. These events were
associated with increased EC surface area and reduced monolayer
size-selective solute permeability. The Y-27632-induced reorganization
of F-actin to - or
-catenin-containing adherens junctions marks
the cytoskeletal events leading to a substantial improvement in
monolayer barrier function. These morphological characteristics are
also identical to those observed after ADP ribosylation of RhoA with C3
exoenzyme or treatment with the MLC kinase inhibitor KT-5926
(4, 9, 14, 20,
23). Thus the increased F-actin observed at cell-cell junctions in C3- and Y-27632-treated EC suggests that this pool of
F-actin is formed when RhoA or ROCK is inhibited.
Rho proteins have been reported to indirectly modulate the formation of integrin-dependent focal adhesion sites at the ends of large F-actin filament bundles (2, 16). In the present study, Y-27632 caused EC to lose paxillin-containing focal adhesions and prevented the thrombin-induced increase in the PY content of paxillin. Y-27632 stimulated a decline in the tyrosine phosphorylation of both paxillin and p125FAK with or without exposure to thrombin, indicating that the thrombin-induced activation of p125FAK may lead, in part, to increased tyrosine phosphorylation of focal adhesions. Taken together, these data suggest that by adjusting the F-actin cytoskeleton, ROCK plays an indirect role in the modulation of focal adhesions and their PY-containing proteins.
Thrombin stimulates actomyosin-based stress fiber contractile forces, causing cell retraction and rounding in EC and neurites (10, 14). In the present study, we tested whether thrombin-induced monolayer barrier dysfunction was due to a contractile mechanism. Y-27632 (10 µM) completely inhibited the biochemical events of thrombin-induced EC contraction by arresting the phosphorylation of MLC and the formation of myosin ribbons linked to F-actin stress fibers. Although this treatment significantly attenuated thrombin-induced monolayer hyperpermeability, Y-27632 did not completely prevent thrombin-induced large hole formation. Thus, thrombin-induced formation of stress fibers and focal adhesions is ROCK dependent, whereas the initiation of large paracellular hole formation appears to be ROCK independent. In addition, thrombin-induced monolayer hyperpermeability is only partially dependent on MLCP and stress fiber formation. A recent study demonstrated that serine/threonine phosphatase inhibitors stimulated monolayer hyperpermeability that appeared to be independent of MLCP (8). Although the MLC kinase inhibitor KT-5926 prevented MLCP, it did not block monolayer hyperpermeability, suggesting that changes in cell-cell adhesion may be involved in the process. Together, these data suggest that thrombin-induced monolayer barrier dysfunction involves both the phosphorylation of MLC leading to EC contraction and cell-cell adhesive mechanisms.
In conclusion, our results confirm recent reports in which Rho proteins have been shown to be important mediators of the cytoskeletal events associated with thrombin. Y-27632 alone stimulated enhanced monolayer barrier function due to an increase in EC surface area resulting from the disassembly of stress fibers and the reorganization of F-actin to cell-cell junctions. In addition, ROCK modulates the thrombin-induced phosphorylation of MLC as well as the formation of myosin ribbons and F-actin stress fibers in EC. However, although thrombin-induced monolayer hyperpermeability is partially dependent on ROCK-stimulated F-actin stress fiber formation, thrombin-induced paracellular hole formation appears to be ROCK independent.
![]() |
ACKNOWLEDGEMENTS |
---|
The authors thank Alex Cohen and Yen Tran for excellent technical contributions and Dr. M. A. Katz for support of this study.
![]() |
FOOTNOTES |
---|
National Institutes of Health Public Health Service Grants RO1-HL-48816-5 and RO1-DK-55151-1 and a Veterans Affairs Merit Review Grant supported this work.
Address for reprint requests and other correspondence: R. C. Schaeffer, Jr., Sidney Kimmel Cancer Center, 10835 Altman Row, San Diego, CA 92121.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Received 25 August 1999; accepted in final form 11 January 2000.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Adelstein, RS,
Pato MD,
and
Conti MA.
The role of phosphorylation in regulating contractile proteins.
Adv Cyclic Nucleotide Res
14:
361-373,
1981[ISI][Medline].
2.
Aepfelbacher, M,
Essler M,
Huber E,
Sugai M,
and
Weber PC.
Bacterial toxins block endothelial wound repair: evidence that Rho GTPases control cytoskeletal rearrangements in migrating endothelial cells.
Arterioscler Thromb Vasc Biol
17:
1623-1629,
1997
3.
Amano, M,
Chihara K,
Kimura K,
Fukata Y,
Nakamura N,
Matsuura Y,
and
Kaibuchi K.
Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase.
Science
275:
1308-1311,
1997
4.
Carbajal, JM,
and
Schaeffer RC, Jr.
ADP ribosylation of Rho proteins reorganizes actomyosin filaments to cell-cell junctions and enhances endothelial barrier function.
Am J Physiol Cell Physiol
277:
C955-C964,
1999
5.
Chong, LD,
Traynor-Kaplan A,
Mokoch GM,
and
Schwartz MA.
The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells.
Cell
79:
507-513,
1994[ISI][Medline].
6.
Craig, SW,
and
Johnson RP.
Assembly of focal adhesions: progress, paradigms and portents.
Curr Opin Cell Biol
8:
74-85,
1996[ISI][Medline].
7.
Dejana, E.
Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis.
J Clin Invest
98:
1949-1953,
1996
8.
Diwan, AH,
Honkanen RE,
Schaeffer RC, Jr,
Strada SJ,
and
Thompson WJ.
Inhibition of serine-threonine protein phosphatases decreased barrier function of rat pulmonary artery endothelial cells.
J Cell Physiol
171:
259-270,
1997[ISI][Medline].
9.
Essler, M,
Amano M,
Kruse H-J,
Kaibuchi K,
Weber PC,
and
Aepfelbacher M.
Thrombin inactivates myosin light chain phosphatase via rho and its target rho kinase in human endothelial cells.
J Biol Chem
273:
21867-21874,
1998
10.
Garcia, JGN,
Verin AD,
and
Schaphorst KL.
Regulation of thrombin-mediated endothelial cell contraction and permeability.
Semin Thromb Hemost
22:
309-315,
1996[Medline].
11.
Goeckeler, ZM,
and
Wysolmerski RB.
Myosin light chain kinase-regulated endothelial cell contraction: the relationship between isometric tension, actin polymerization and myosin phosphorylation.
J Cell Biol
130:
613-627,
1995[Abstract].
12.
Hartshorne, DJ,
and
Kawamura T.
Regulation of contraction-relaxation in smooth muscle.
News Physiol Sci
7:
59-64,
1992
13.
Hippenstiel, S,
Tannert-Otto S,
Vollrath N,
Krull M,
Just I,
Aktories K,
Von Eichel-Streiber C,
and
Suttorp N.
Glucosylation of small GTP-binding Rho proteins disrupts endothelial barrier function.
Am J Physiol Lung Cell Mol Physiol
272:
L38-L43,
1997
14.
Jalink, K,
van Corven EJ,
Hengeveld T,
Morii N,
Narumiya S,
and
Moolenaar WH.
Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho.
J Cell Biol
126:
801-810,
1994[Abstract].
15.
Kimura, K,
Ito M,
Amano M,
Chihara K,
Fukata Y,
Nadafuku M,
Yamamori B,
Feng J,
Nakano T,
Okawa K,
Iwamatsu A,
and
Kaibuchi K.
Regulation of myosin phosphatase by Rho and Rho-associated kinase (rho-kinase).
Science
273:
245-248,
1996[Abstract].
16.
Laudanna, C,
Campbell JJ,
and
Butcher EC.
Role of Rho in chemoattractant-activated leukocyte adhesion through integrins.
Science
271:
981-983,
1996[Abstract].
17.
Lum, H,
and
Malik AB.
Mechanisms of increased endothelial permeability.
Can J Physiol Pharmacol
74:
787-800,
1996[ISI][Medline].
18.
Maekawa, M,
Ishizaki T,
Boku S,
Watanabe N,
Fujita A,
Iwamatsu A,
Obinata T,
Ohashi K,
Mizuno K,
and
Narumiya S.
Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase.
Science
285:
895-898,
1999
19.
Nakai, K,
Suzuki Y,
Kihra H,
Wada H,
Fujioka M,
Ito M,
Nakano T,
Kaibuchi K,
Shiku H,
and
Nishikawa M.
Regulation of myosin phosphatase through phosphorylation of the myosin binding subunit in platelet activation.
Blood
90:
3936-3942,
1997
20.
Patterson, CE,
Davis HW,
Schaphorst KL,
and
Garcia JGN
Mechanisms of cholera toxin prevention of thrombin- and PMA-induced endothelial barrier dysfunction.
Microvasc Res
48:
212-235,
1994[ISI][Medline].
21.
Ridley, AJ,
and
Hall A.
The small GTP-binding protein Rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.
Cell
70:
389-399,
1992[ISI][Medline].
22.
Schaeffer, RC, Jr,
and
Bitrick MS, Jr.
Effects of human -thrombin and 8bromo-cAMP on large and microvessel endothelial monolayer equivalent "pore" radii.
Microvasc Res
49:
364-371,
1995[ISI][Medline].
23.
Schaeffer, RC, Jr,
Cohen AW,
Pusch CJ,
and
Seitz KA.
Cyclic AMP and KT-5926 initiate p125FAK phosphorylation and paxillin appearance at bovine pulmonary artery endothelial cell-cell junctions (Abstract).
Mol Biol Cell
7:
386a,
1996.
24.
Schaeffer, RC, Jr,
Gong FC,
and
Bitrick MS, Jr.
Restricted diffusion of macromolecules by endothelial monolayers and small pore filters.
Am J Physiol Lung Cell Mol Physiol
263:
L27-L36,
1992
25.
Schaeffer, RC, Jr,
Gong FC,
Bitrick MS, Jr,
and
Smith TL.
Thrombin and bradykinin initiate discrete endothelial solute permeability mechanisms.
Am J Physiol Heart Circ Physiol
264:
H1798-H1809,
1993
26.
Schaeffer, RC, Jr,
Renkiewicz RR,
Chilton S-M,
Marsh D,
and
Carlson RW.
Preparation and high-performance size-exclusion chromatographic analysis of fluorescein isothiocyanate-hydroxy ethyl starch: macromolecular probes of the blood-lymph barrier.
Microvasc Res
32:
230-243,
1986[ISI][Medline].
27.
Uehata, M,
Ishizaki T,
Satoh H,
Ono T,
Kawahara T,
Morishita T,
Tamakawa H,
Yamagami K,
Inui J,
Maekawa M,
and
Narumiya S.
Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension.
Nature
389:
990-994,
1997[ISI][Medline].
28.
Verkhovsky, AB,
Svitkina TM,
and
Borisy GG.
Myosin II filament assembly in the active lamella of fibroblasts: their morphogenesis and role in the formation of actin filament bundles.
J Cell Biol
131:
989-1002,
1995[Abstract].
29.
Zhang, J,
King WG,
Dillon S,
Hall A,
Feig L,
and
Rittenhouse SE.
Activation of platelet phosphatidylinositide 3-kinase requires the small GTP-binding protein Rho.
J Biol Chem
268:
22251-22254,
1993